Evidence map›Paper›PMID 38482414›Full record

ArticleTranslational cancer research2024

Chunjian Qiu, Yao Yao, Suqin Hu, Yixin Xu

Open access · diamondAbstract read
In one paragraph

Article in Translational cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Chunjian Qiu *Department of Psychiatry, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Yao Yao *Department of Outpatient, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Suqin HuDepartment of Psychiatry, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Yixin XuDepartment of Endocrinology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Nanjing University · CNNanjing General Hospital of Nanjing Military Command · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pituitary adenomas (PAs) are prevalent intracranial tumors necessitating a comprehensive exploration of their molecular intricacies. This study delved into the molecular interactions among Methods: Our in-depth bioinformatics analysis identified Results: Conclusions: In summary, our research uncovered a complex regulatory interplay among

Indexed as

autophagyhairy and enhancer of split 1 (HES1)inositol 1,4,5-trisphosphate receptor, type 1 (ITPR1)Pituitary adenomas (PAs)tumor metastasis

Identifiers

PMID38482414
PMCPMC10928634
OpenAlexW4392301072

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.